IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q2 2022 Holdings

Filed 2022-08-03 | 7 holdings | $43.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2022-08-03) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aura Biosciences Inc(AURA)COM05153U107$43.1M3,039,89299.5%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$97.2K19,963,1570.2%
Vaxcyte Inc(PCVX)COM92243G108$41.1K1,887,4780.1%
Merus N VCOMN5749R100$36.2K1,600,0000.1%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$20.7K2,450,6790.0%
Obseva SACOMH5861P103$2.5K1,570,0000.0%
Checkmate Pharmaceuticals inCOM162818108$000.0%